Outcomes of Second Trabeculectomy Versus Glaucoma Drainage Device in Juvenile Open Angle Glaucoma After Primary Trabeculectomy Failure.
Kasem Seresirikachorn, Kornkamol Annopawong, Nucharee Parivisutt, Boonsong Wanichwecharungruang, David S Friedman, Daniel M Vu
Summary
Both second trabeculectomy and GDD insertion are effective treatments for JOAG after trabeculectomy failure. The second trabeculectomy required fewer medications for intraocular pressure control.
Abstract
PRCIS
Second trabeculectomy and glaucoma drainage device implantation offer similar success rates for juvenile open angle glaucoma after initial trabeculectomy failure. However, second trabeculectomies required fewer medications. A quarter of patients in both groups required a third operation after 2.5±2.3 years.
PURPOSE
To compare outcomes between second trabeculectomy surgery versus glaucoma drainage device (GDD) insertion in juvenile open angle glaucoma (JOAG) patients after primary trabeculectomy failure.
METHOD
A retrospective review was performed on all JOAG patients who underwent a second glaucoma surgery after primary trabeculectomy failure across 2 tertiary hospitals in Bangkok, Thailand between 2009 and 2020. Demographics, intraoperative reports, and clinical findings were collected. The primary outcomes were complete and qualified success rates at 5 years; secondary outcomes included differences in intraocular pressures and a number of glaucoma medications postoperatively.
RESULTS
Fifty-two eyes of 38 patients underwent a second glaucoma surgery after primary trabeculectomy: 30 had a second trabeculectomy, 17 received a GDD (10 valved, 7 non-valved), and 5 underwent cyclophotocoagulation. Before surgery, there were no significant differences except in mean refractive error. The average follow-up length was 66.9±53.7 months. Qualified success rates were 81.5% and 63.2% at 3 and 5 years (complete success: 55.6% and 42.1%) for the second trabeculectomy group and 80.0% and 70.0% (complete success: 53.3% and 50.0%) for the GDD group, respectively. There were no significant differences in group success or IOP postoperatively. The GDD group required more medications at 5 years (1.3±1.9 vs. 2.3±1.5, P =0.03). Two cases of tube exposure in the GDD group resulted in implant removal. About a quarter of patients in both groups required a third operation after 2.5±2.3 years.
CONCLUSION
Both second trabeculectomy and GDD insertion are effective treatments for JOAG after trabeculectomy failure. The second trabeculectomy required fewer medications for intraocular pressure control.
More by Kasem Seresirikachorn
View full profile →Deep Learning for Anterior Segment Optical Coherence Tomography to Predict the Presence of Plateau Iris.
Treatment Patterns of Childhood Glaucoma in the United States: Analysis of IRISRegistry (Intelligent Research in Sight).
Use of Diagnostic Codes for Primary Open-Angle Glaucoma Polygenic Risk Score Construction in Electronic Health Record-Linked Biobanks.
Top Research in Glaucoma Surgery
Browse all →Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.